A third top tier recruitment to strengthen sales and marketing

Ex-Lonza senior executive Reto Renggli joins Hofseth BioCare. The new addition to the team is the last in a series of new hires and agreements focusing on ramping up sales and international growth.
Reto

Mr. Renggli is a highly accomplished leader with two decades of global experience in marketing, business development and the sales of scientific based branded raw materials to the human and pet food sector.

He is the former Head of Sales and Marketing, Health Ingredients at Lonza, the Swiss based life sciences business and has broad experience of developing new products. He managed key commercial relationships with multinationals such as Nestle and Danone.

“I was inspired to join HBC’s senior leadership team by the global opportunity I see for this rapidly growing biotech business. As we accelerate plans to commercialise and expand HBC’s product and ingredient ranges, our skills and experience are set to prove complementary”, says Reto Renggli.

The hiring of Renggli follows in the wake of a series of initiatives the latest months. HBC is focused on its expansion across the entire consumer health sector and the creation of a global distribution network for its range of products and ingredients.

  • Hiring of Andy Gill, formerly of GSK and Novartis,and Will Urban-Smith, formerly of Johnson & Johnson. (sett inn lenker)
  • DKSH market expansion company to distribute HBC across Asia (sett inn lenke)
  • Groundbreaking contract with global ingredient distributor IMCD (sett inn lenke)
  • These agreements and recruitments follow the granting of a unique set of label claims for its bioactive peptide product ProGo® in North America, centred around the treatment of iron deficiency anemia. (sett inn lenke)

“Hiring Reto Renggli is a significant milestone for HBC and we are delighted he will be working alongside Andy and Will. These experienced sales executives from Tier One, global pharmaceutical and nutraceutical consumer health businesses will drive sales of HBC´s unique, sustainable, science and claim-backed natural health solutions.”, says CEO Roger Hofseth of Hofseth BioCare ASA.